These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
53 related items for PubMed ID: 14671222
1. The value of the low-dose dexamethasone suppression test in the differential diagnosis of hyperandrogenism in women. Rosenfield RL, Barnes RB, Ehrmann DA, Toledano AY. J Clin Endocrinol Metab; 2003 Dec; 88(12):6115; author reply 6115-6. PubMed ID: 14671222 [No Abstract] [Full Text] [Related]
2. Discriminatory value of low-dose dexamethasone suppression test in establishing the diagnosis and differential diagnosis of Cushing's syndrome. Zarkovic M, Ciric J, Beleslin B, Penezic Z. J Clin Endocrinol Metab; 2004 Mar; 89(3):1486; author reply 1486. PubMed ID: 15001654 [No Abstract] [Full Text] [Related]
3. Discriminatory value of the low-dose dexamethasone suppression test in establishing the diagnosis and differential diagnosis of Cushing's syndrome. Isidori AM, Kaltsas GA, Mohammed S, Morris DG, Jenkins P, Chew SL, Monson JP, Besser GM, Grossman AB. J Clin Endocrinol Metab; 2003 Nov; 88(11):5299-306. PubMed ID: 14602765 [Abstract] [Full Text] [Related]
4. Nocturnal 8 mg dexamethasone suppression test: a practical and accurate test for identification of the cause of endogenous Cushing's syndrome. Sriussadaporn S, Ploybutr S, Peerapatdit T, Plengvidhya N, Nitiyanant W, Vannasaeng S, Vichayanrat A. Br J Clin Pract; 1996 Nov; 50(1):9-13. PubMed ID: 8729595 [Abstract] [Full Text] [Related]
5. Comparison of efficacy between 1 mg overnight dexamethasone suppression test and 2-day low dose dexamethasone suppression test for diagnosis of Cushing's syndrome. Kungpanichkul N. J Med Assoc Thai; 2010 Jan; 93(1):27-33. PubMed ID: 20196407 [Abstract] [Full Text] [Related]
6. A dose-response study of salivary cortisol after dexamethasone suppression test in Cushing's disease and its potential use in the differential diagnosis of Cushing's syndrome. Castro M, Elias LL, Elias PC, Moreira AC. Clin Endocrinol (Oxf); 2003 Dec; 59(6):800-5. PubMed ID: 14974925 [Abstract] [Full Text] [Related]
7. The low-dose dexamethasone suppression test: a reevaluation in patients with Cushing's syndrome. Findling JW, Raff H, Aron DC. J Clin Endocrinol Metab; 2004 Mar; 89(3):1222-6. PubMed ID: 15001614 [Abstract] [Full Text] [Related]
8. Dexamethasone suppression test in the management of hyperandrogenized patients. Abraham GE, Maroulis GB, Boyers SP, Buster JE, Magyar DM, Elsner CW. Obstet Gynecol; 1981 Feb; 57(2):158-65. PubMed ID: 6450905 [Abstract] [Full Text] [Related]
14. Cortisol and ACTH response to oral dexamethasone in obesity and effects of sex, body fat distribution, and dexamethasone concentrations: a dose-response study. Pasquali R, Ambrosi B, Armanini D, Cavagnini F, Uberti ED, Del Rio G, de Pergola G, Maccario M, Mantero F, Marugo M, Rotella CM, Vettor R, Study Group on Obesity of the Italian Society of Endocrinology. J Clin Endocrinol Metab; 2002 Jan 07; 87(1):166-75. PubMed ID: 11788642 [Abstract] [Full Text] [Related]
17. Comparison of results of adrenocorticotropic hormone stimulation and low-dose dexamethasone suppression tests with necropsy findings in dogs: 81 cases (1985-1995). Van Liew CH, Greco DS, Salman MD. J Am Vet Med Assoc; 1997 Aug 01; 211(3):322-5. PubMed ID: 9262671 [Abstract] [Full Text] [Related]